Search
Now showing items 1-10 of 18
Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital.
(Namusoke, J. (2014). Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital. Unpublished masters thesis. Makerere University, Kampala, Uganda., 2014)
Introduction
Western studies have described and noted an increased prevalence rate of osteoporosis in HIV infected patients. The causes of osteoporosis in this population appear to be multifactorial and likely represent ...
Factors influencing the acceptance of directly observed therapy in the delivery of anti-retroviral drugs for treatment of Human Immunodeficiency Virus in Urban Uganda
(2008-05)
Background: Directly observed therapy for highly active antiretroviral therapy (DOT-HAART) has the potential to improve adherence and social support in HIV+ patients. Aims were to determine; the level of DOT-HAART acceptance, ...
Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey
(BioMed Central, 2010)
Background: Low concentrations of serum zinc have been reported in HIV infected adults and are associated with disease progression and an increased risk of death. Few studies have been conducted in HIV infected children ...
Factors affecting adherence to cotrimoxazole prophylaxis among HIV/AIDS patients in Rukungiri District, Uganda.
(2009)
INTRODUCTION:
Globally, 33 million people are estimated to be living with HIV of which 22 million are in sub Saharan Africa. In Rukungiri district, 20115 people were estimated to be living with HIV/AIDS. With adherence ...
Evaluation of patients' response to treatment with highly active antiretroviral therapy at the Infectious Diseases Institute, Kampala.
(2009-10)
BACKGROUND:
In Africa, a consideration number of clients get diagnosed with HIV for the first time after a WHO stage 4 illness. Evidence in the developed world shows that individuals who initiate ART with advanced HIV/AIDS ...
In vivo PPD reactivity and associated factors among HIV positive patients on HAART at the Makerere University Infectious Diseases Clinic.
(2009-08)
BACKGROUND:
It is estimated that a third of the world’s population is infected with tuberculosis (TB).
This epidemic is fueled by HIV, with reactivation rates of 8-10% / year and overall lifetime risk of 30% in HIV ...
Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods a prospective cohort study
(Adis, 2012-10)
Background: The effectiveness of traditional adherence measurements used in adolescent populations isdifficult to assess. Antiretroviral (ARV) adherence research among adolescents living with HIV in resourceconstrained ...
Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy
(CID, 2008)
Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of persons with acquired immunodeficiency syndrome in Africa. Methods. Two prospective, observational cohorts enrolled human immunodeficiency ...
Coping with TB immune reconstitution inflammatory syndrome
(Expert Reviews, 2009)
The TB immune reconstitution inflammatory syndrome (IRIS) is a relatively frequent complication in HIV–TB-coinfected patients after they start highly active antiretroviral therapy (HAART). There are two forms of TB IRIS: ...
Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: role of depression in declining adherence over time.
(Springer, 2009-03-20)
We conducted a study to assess the effect of family-based treatment on adherence amongst HIV-infected parents and their HIV-infected children attending the Mother-To-Child-Transmission Plus program in Kampala, Uganda. ...